Legato Capital Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $348K | Sell |
37,005
-86
| -0.2% | -$809 | 0.04% | 485 |
|
|
2025
Q1 | $201K | Sell |
37,091
-451
| -1% | -$2.44K | 0.03% | 514 |
|
|
2024
Q4 | $280K | Sell |
37,542
-11,238
| -23% | -$83.7K | 0.04% | 504 |
|
|
2024
Q3 | $390K | Buy |
48,780
+29,343
| +151% | +$234K | 0.05% | 472 |
|
|
2024
Q2 | $169K | Sell |
19,437
-52,297
| -73% | -$455K | 0.02% | 525 |
|
|
2024
Q1 | $1.48M | Buy |
71,734
+12,387
| +21% | +$256K | 0.18% | 188 |
|
|
2023
Q4 | $1.37M | Sell |
59,347
-18,054
| -23% | -$417K | 0.18% | 178 |
|
|
2023
Q3 | $618K | Sell |
77,401
-3,677
| -5% | -$29.4K | 0.09% | 347 |
|
|
2023
Q2 | $705K | Buy |
81,078
+4,948
| +6% | +$43K | 0.1% | 328 |
|
|
2023
Q1 | $224K | Hold |
76,130
| – | – | 0.04% | 436 |
|
|
2022
Q4 | $266K | Buy |
+76,130
| New | +$266K | 0.05% | 418 |
|